The relationship between differential placental protein expressions and insulin resistance: a systematic review and meta-analysis_West China Medical Journal

Authors：

HUANG Pingping ¹ , GE Li ¹ ,  MIAO Haiyan ² , WANG Guandong ¹ , LAI Yuting ¹ , JIANG Xinyong ¹ , CHEN Fan ¹ , PANG Shuqin ¹ , YU Honghong ¹

1. School of Nursing, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P. R. China;
2. Department of Obstetrics and Gynecology, the Second People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350003, P. R. China;

Corresponding?author：

MIAO Haiyan, Email: 573764301@qq.com

Keywords：

Gestational diabetes mellitus; Placenta; Placental protein; Insulin resistance; Systematic review

DOI：

10.7507/1002-0179.201911079

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To systematically evaluate the changes in placental protein expressions in gestational diabetes mellitus (GDM) and their correlations with maternal insulin resistance (IR). Methods PubMed, Cochrane Library, Scopus, Web of Science, Embase, China National Knowledge Infrastructure, VIP database, Wanfang Database and CBMdisc were searched for case-control studies published from January 2009 to November 2021, which reported the placental protein expressions in GDM and their correlations with IR. Two researchers independently reviewed the literature, extracted data and evaluated the literature quality. RevMan 5.4 software was used for meta-analysis, and descriptive analysis was performed on data that cannot be combined. Results A total of 19 studies were included, comprising 2 012 patients. The results of meta-analysis showed that: the expression level of retinol binding protein 4 (RBP4) [standard mean difference=2.11, 95% confidence interval (CI) (1.64, 2.58), P<0.000 01] and the positive rate of protein tyrosine phosphatase-1B (PTP1B) [relative risk (RR)=1.56, 95%CI (1.29, 1.88), P<0.000 01] were up-regulated, and the positive rate of insulin receptor substrate 1 (IRS-1) [RR=0.69, 95%CI (0.60, 0.78), P<0.000 01] was down-regulated. The protein expression levels of RBP4 (P<0.000 01) and PTP1B (P<0.000 01) were positively correlated with homeostasis model assessment of insulin resistance (HOMA-IR), while the protein expression levels of IRS-1 (P<0.000 01) and APN (P=0.002) were negatively correlated with HOMA-IR, and glucose transporter 4 (GLUT 4) was not correlated with HOMA-IR (P=0.79). Descriptive analysis found that the expression levels or positive rates of adipocytokines (leptin, resistin), oxidative stress markers (xanthione oxidase, malondialdehyde, 8-isoprostaglandin),inflammatory factors (tumor necrosis factor α, Toll-like receptor 4, Galectin-3, Galectin-2, migration inhibitory factor),fetuin-A, forkhead box transcription factor 1, forkhead box transcription factor 3a and estrogen receptor α in GDM placenta were up-regulated and all were positively correlated with HOMA-IR. The expression levels or positive rates of insulin signaling pathway proteins [phosphoinositide 3-kinase (PI3K), protein kinases B (AKT), phospho-protein kinases B (p-AKT), GLUT 4] were down-regulated, PI3K and AKT were negatively correlatedwith HOMA-IR, while p-Akt had no correlation with HOMA-IR. Conclusions The dysregulation of placental protein expressions may mediate maternal IR exacerbation, thus promote the occurrence and development of GDM and other pregnancy complications. The causal relationship and regulatory mechanism are still unclear, which need to be further studied.

Citation： HUANG Pingping, GE Li, MIAO Haiyan, WANG Guandong, LAI Yuting, JIANG Xinyong, CHEN Fan, PANG Shuqin, YU Honghong. The relationship between differential placental protein expressions and insulin resistance: a systematic review and meta-analysis. West China Medical Journal, 2021, 36(12): 1705-1715. doi: 10.7507/1002-0179.201911079 Copy

1.	Nguyen-Ngo C, Jayabalan N, Salomon C, et al. Molecular pathways disrupted by gestational diabetes mellitus. J Mol Endocrinol, 2019, 63(3): R51-R72.
2.	Powe CE. Early pregnancy biochemical predictors of gestational diabetes mellitus. Curr Diab Rep, 2017, 17(2): 12.
3.	Liang Z, Zhou M, Xu XK, et al. Is chemerin associated with gestational diabetes mellitus? An evidence-based clinical research from Chinese women. J Obstet Gynaecol, 2018, 38(4): 482-487.
4.	Wedekind L, Belkacemi L. Altered cytokine network in gestational diabetes mellitus affects maternal insulin and placental-fetal development. J Diabetes Complications, 2016, 30(7): 1393-1400.
5.	Xu Y, Jin B, Sun L, et al. The expression of FoxO1 in placenta and omental adipose tissue of gestational diabetes mellitus. Exp Clin Endocrinol Diabetes, 2014, 122(5): 287-294.
6.	張凌燕, 張曉姍, 折開娥, 等. 妊娠期糖尿病孕婦血清和胎盤組織中 FOXO3a 的表達水平及其與胰島素抵抗的關系. 中國婦幼保健, 2018, 33(19): 4405-4408.
7.	高秀秀, 甘旭培, 徐先明. 妊娠期糖尿病孕婦胎盤中視黃醇結合蛋白 4 表達與胰島素抵抗和胰島素分泌功能的相關性. 現代婦產科進展, 2016, 25(10): 750-753.
8.	Liu B, Xu Y, Voss C, et al. Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathways. PLoS One, 2012, 7(9): e44701.
9.	Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
10.	Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions (Version 5.1. 0). (2011-03-20)[2019-11-01]. http://handbook-5-1.cochrane.org/.
11.	葛芳君, 趙磊, 劉俊, 等. 基于 Pearson 相關系數的老年人社會支持與心理健康相關性研究的 Meta 分析. 中國循證醫學雜志, 2012, 12(11): 1320-1329.
12.	Tsiligianni I, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J, 2011, 20(3): 257-268.
13.	夏雨果, 陳秋, 湯志梅, 等. 氧化應激產物 MDA 與生育力和精子參數相關性的 Meta 分析. 海南醫學, 2018, 29(9): 1316-1320.
14.	曾麗, 王佳琳, 左敏, 等. 中國老年人睡眠質量與社會支持相關性的 Meta 分析. 中國循證醫學雜志, 2021, 21(4): 401-406.
15.	李凡, 王如萍, 況雪靜, 等. 胎盤組織中 GLUT4、RBP4 表達與妊娠糖尿病發病的關系. 臨床和實驗醫學雜志, 2020, 19(12): 1319-1322.
16.	郭永, 付竹梅. 妊娠期糖尿病孕婦中視黃醇結合蛋白 4 的表達與胰島素抵抗的關系. 濰坊醫學院學報, 2017, 39(2): 108-110.
17.	任宏珍. 妊娠期糖尿病產婦胎盤組織中蛋白酪氨酸磷酸酶 1B 的表達及其與胰島素抵抗和炎癥應激的相關性. 中國婦幼保健, 2018, 33(16): 3679-3683.
18.	王麗娜, 崔文華, 梁珊, 等. 妊娠期糖尿病患者胎盤組織胰島素受體底物 1、蛋白酪氨酸磷酸酶 1B 表達及意義. 山東醫藥, 2015, 55(40): 56-58.
19.	高曉麗. 蛋白酪氨酸磷酸酶 1B 與妊娠期糖尿病的相關性研究. 天津: 天津醫科大學, 2010.
20.	馮衛紅, 王艷霞, 計靜, 等. IRS-1 和 GLUT4 在妊娠期糖尿病患者胎盤組織中的表達水平及其臨床意義. 中國婦產科臨床雜志, 2020, 21(3): 251-253.
21.	馬宗麗, 秦智娟, 肖黎明, 等. 妊娠期糖尿病產婦胎盤組織中 TLR4/MyD88/NF-κB 的表達及其與胰島素抵抗的相關性. 中國臨床研究, 2020, 33(12): 1620-1623.
22.	禤文婷, 陳麗霞, 黎美金, 等. Galectin-2 在妊娠期糖尿病患者中的表達及其與胰島素抵抗的關系. 醫學信息, 2020, 33(16): 72-74.
23.	楊云萍, 劉春玲. 半乳糖凝集素 3 在妊娠期糖尿病孕婦中表達及與胰島素抵抗關系. 中國計劃生育學雜志, 2019, 27(1): 77-79, 83.
24.	鄭林, 李超, 齊衛紅, 等. 巨噬細胞移動抑制因子基因在胎盤組織中表達與妊娠期糖尿病的相關性. 中華醫學雜志, 2017, 97(43): 3388-3391.
25.	李華珍, 袁俏奇, 羅利, 等. 妊娠期糖尿病產婦胎盤與血清脂聯素水平的相關性. 中南醫學科學雜志, 2016, 44(3): 255-257.
26.	左嬋. 探討脂聯素在妊娠期糖尿病發病機制中的相關作用. 湛江: 廣東醫學院, 2012.
27.	李明. PI3K/AKT 信號通路與妊娠期糖尿病胰島素抵抗的關系. 天津: 天津醫科大學, 2010.
28.	曹聰明, 丁紅濤, 李妙榮. 妊娠期糖尿病患者胎盤組織中胎球蛋白 A 的表達及其與胰島素抵抗的關系. 中國醫師進修雜志, 2014, 37(27): 7-9.
29.	周玉彬, 李超, 喬炳龍, 等. 妊娠期糖尿病患者胎盤組織中雌激素與雌激素受體α水平變化及相關因素分析. 中華糖尿病雜志, 2017, 9(11): 688-692.
30.	Shang M, Dong X, Hou L. Correlation of adipokines and markers of oxidative stress in women with gestational diabetes mellitus and their newborns. J Obstet Gynaecol Res, 2018, 44(4): 637-646.
31.	Johns EC, Denison FC, Norman JE, et al. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends in Endocrinol Metab, 2018, 29(11): 743-754.
32.	Koning SH, Hoogenberg K, Lutgers HL, et al. Gestational diabetes mellitus: current knowledge and unmet needs. J Diabetes, 2016, 8(6): 770-781.
33.	Feng H, Su R, Song Y, et al. Positive correlation between enhanced expression of TLR4/MyD88/NF-κB with insulin resistance in placentae of gestational diabetes mellitus. PloS one, 2016, 11(6): e0157185.
34.	Plows JF, Stanley JL, Baker PN, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci, 2018, 19(11): 3342.
35.	Low Birth Weight and Nephron Number Working Group. The impact of kidney development on the life course: a consensus document for action. Nephron, 2017, 136(1): 3-49.
36.	Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest, 2005, 115(5): 1111-1119.
37.	Liang ZX, Du MK, Fang Q, et al. Significance of RBP4 in patients with gestational diabetes mellitus: a case-control study of Han Chinese women. Gynecol Endocrinol, 2014, 30(2): 161-164.
38.	劉嗣超, 劉星. PAI-1、GLUT1 及 RBP4 在妊娠期糖尿病患者胎盤組織中的表達及臨床意義. 中國婦幼保健, 2019, 34(19): 4430-4433.
39.	Pérez-Pérez A, Maymó J, Gambino Y, et al. Insulin enhances leptin expression in human trophoblastic cells. Biol Reprod, 2013, 89(1): 20.
40.	Pérez-Pérez A, Guadix P, Maymó J, et al. Insulin and leptin signaling in placenta from gestational diabetic subjects. Horm Metab Res, 2016, 48(1): 62-69.
41.	Hu S, Liu Q, Huang X, et al. Serum level and polymorphisms of retinol-binding protein-4 and risk for gestational diabetes mellitus: a meta-analysis. BMC Pregnancy Childbirth, 2016, 16: 52.
42.	Sudharshana Murthy KA, Bhandiwada A, Chandan SL, et al. Evaluation of oxidative stress and proinflammatory cytokines in gestational diabetes mellitus and their correlation with pregnancy outcome. Indian J Endocrinol Metab, 2018, 22(1): 79-84.
43.	Tabák AG, Carstensen M, Witte DR, et al. Adiponectin trajectories before type 2 diabetes diagnosis: WhitehallⅡstudy. Diabetes Care, 2012, 35(12): 2540-2547.
44.	Siddiqui K, George TP, Nawaz SS, et al. Serum adipokines (adiponectin and resistin) correlation in developing gestational diabetes mellitus: pilot study. Gynecol Endocrinol, 2018, 34(6): 502-506.
45.	Asemi Z, Jazayeri S, Najafi M, et al. Association between markers of systemic inflammation, oxidative stress, lipid profiles, and insulin resistance in pregnant women. ARYA Atheroscler, 2013, 9(3): 172-178.
46.	Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes, 2002, 51(7): 2207-2213.
47.	Xu J, Zhao YH, Chen YP, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. Sci World J, 2014, 2014: 926932.
48.	趙莉莉, 楊筱青. 妊娠期糖尿病 TNF-α與 VCAM-1 的表達及相關性研究. 醫學研究雜志, 2019, 48(4): 78-82.
49.	Khambule L, George JA. The role of inflammation in the development of GDM and the use of markers of inflammation in GDM screening. Adv Exp Med Biol, 2019, 1134: 217-242.
50.	楊娟, 佘美華. FoxO1 在 2 型糖尿病中的作用及其研究進展. 中南醫學科學雜志, 2017, 45(3): 307-311.
51.	侯少聰, 李平平. 半乳糖苷凝集素 Galectin3 直接誘發胰島素抵抗. 中國細胞生物學學報, 2017, 39(5): 537-541.
52.	Hepp P, Unverdorben L, Hutter S, et al. Placental galectin-2 expression in gestational diabetes: a systematic, histological analysis. Int J Mol Sci, 2020, 21(7): 2404.
53.	馮慧, 馬京梅, 楊慧霞. 妊娠期糖尿病孕婦足月胎盤 Toll 樣受體 4 的表達分布. 中華圍產醫學雜志, 2016, 19(5): 350-354.
54.	王運林, 姚培偉, 張曉婷. 炎性因子 hs-CRP、MIF 和 RANTES 在不同糖代謝人群中的表達及其與胰島素抵抗的關系. 廣東醫學, 2015, 36(12): 1897-1899.
55.	李高振, 宋曉燕. 巨噬細胞移動抑制因子及腫瘤壞死因子-α在妊娠期糖尿病臨床診斷中的應用價值. 實用臨床醫藥雜志, 2017, 21(23): 86-87.
56.	Shang M, Zhao J, Yang L, et al. Oxidative stress and antioxidant status in women with gestational diabetes mellitus diagnosed by IADPSG criteria. Diabetes Res Clin Pract, 2015, 109(2): 404-410.
57.	張亞楠, 陳保民, 高陽, 等. FoxO3a 轉錄因子與機體氧化應激損傷的研究進展. 醫學研究生學報, 2016, 29(3): 327-331.
58.	楊猛, 高天虹. 蛋白酪氨酸磷酸酶 1B (PTP1B) 抑制劑的研究進展. 河南化工, 2015, 32(1): 11-15.
59.	Akbas H, Kahraman S, Sak S, et al. Minor variant of AHSG gene 767C> G polymorphism may decrease the risk of gestational diabetes mellitus. J Obstet Gynaecol, 2020, 40(3): 303-307.
60.	王雨艷, 黃達, 沈秀敏, 等. 雌激素受體和孕激素受體在妊娠期高血壓疾病胎盤組織中的表達. 解剖科學進展, 2015, 21(6): 621-623.
61.	Barros RP, Morani A, Moriscot A, et al. Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4. Mol Cell Endocrinol, 2008, 295(1/2): 24-31.

1. Nguyen-Ngo C, Jayabalan N, Salomon C, et al. Molecular pathways disrupted by gestational diabetes mellitus. J Mol Endocrinol, 2019, 63(3): R51-R72.
2. Powe CE. Early pregnancy biochemical predictors of gestational diabetes mellitus. Curr Diab Rep, 2017, 17(2): 12.
3. Liang Z, Zhou M, Xu XK, et al. Is chemerin associated with gestational diabetes mellitus? An evidence-based clinical research from Chinese women. J Obstet Gynaecol, 2018, 38(4): 482-487.
4. Wedekind L, Belkacemi L. Altered cytokine network in gestational diabetes mellitus affects maternal insulin and placental-fetal development. J Diabetes Complications, 2016, 30(7): 1393-1400.
5. Xu Y, Jin B, Sun L, et al. The expression of FoxO1 in placenta and omental adipose tissue of gestational diabetes mellitus. Exp Clin Endocrinol Diabetes, 2014, 122(5): 287-294.
6. 張凌燕, 張曉姍, 折開娥, 等. 妊娠期糖尿病孕婦血清和胎盤組織中 FOXO3a 的表達水平及其與胰島素抵抗的關系. 中國婦幼保健, 2018, 33(19): 4405-4408.
7. 高秀秀, 甘旭培, 徐先明. 妊娠期糖尿病孕婦胎盤中視黃醇結合蛋白 4 表達與胰島素抵抗和胰島素分泌功能的相關性. 現代婦產科進展, 2016, 25(10): 750-753.
8. Liu B, Xu Y, Voss C, et al. Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathways. PLoS One, 2012, 7(9): e44701.
9. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
10. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions (Version 5.1. 0). (2011-03-20)[2019-11-01]. http://handbook-5-1.cochrane.org/.
11. 葛芳君, 趙磊, 劉俊, 等. 基于 Pearson 相關系數的老年人社會支持與心理健康相關性研究的 Meta 分析. 中國循證醫學雜志, 2012, 12(11): 1320-1329.
12. Tsiligianni I, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J, 2011, 20(3): 257-268.
13. 夏雨果, 陳秋, 湯志梅, 等. 氧化應激產物 MDA 與生育力和精子參數相關性的 Meta 分析. 海南醫學, 2018, 29(9): 1316-1320.
14. 曾麗, 王佳琳, 左敏, 等. 中國老年人睡眠質量與社會支持相關性的 Meta 分析. 中國循證醫學雜志, 2021, 21(4): 401-406.
15. 李凡, 王如萍, 況雪靜, 等. 胎盤組織中 GLUT4、RBP4 表達與妊娠糖尿病發病的關系. 臨床和實驗醫學雜志, 2020, 19(12): 1319-1322.
16. 郭永, 付竹梅. 妊娠期糖尿病孕婦中視黃醇結合蛋白 4 的表達與胰島素抵抗的關系. 濰坊醫學院學報, 2017, 39(2): 108-110.
17. 任宏珍. 妊娠期糖尿病產婦胎盤組織中蛋白酪氨酸磷酸酶 1B 的表達及其與胰島素抵抗和炎癥應激的相關性. 中國婦幼保健, 2018, 33(16): 3679-3683.
18. 王麗娜, 崔文華, 梁珊, 等. 妊娠期糖尿病患者胎盤組織胰島素受體底物 1、蛋白酪氨酸磷酸酶 1B 表達及意義. 山東醫藥, 2015, 55(40): 56-58.
19. 高曉麗. 蛋白酪氨酸磷酸酶 1B 與妊娠期糖尿病的相關性研究. 天津: 天津醫科大學, 2010.
20. 馮衛紅, 王艷霞, 計靜, 等. IRS-1 和 GLUT4 在妊娠期糖尿病患者胎盤組織中的表達水平及其臨床意義. 中國婦產科臨床雜志, 2020, 21(3): 251-253.
21. 馬宗麗, 秦智娟, 肖黎明, 等. 妊娠期糖尿病產婦胎盤組織中 TLR4/MyD88/NF-κB 的表達及其與胰島素抵抗的相關性. 中國臨床研究, 2020, 33(12): 1620-1623.
22. 禤文婷, 陳麗霞, 黎美金, 等. Galectin-2 在妊娠期糖尿病患者中的表達及其與胰島素抵抗的關系. 醫學信息, 2020, 33(16): 72-74.
23. 楊云萍, 劉春玲. 半乳糖凝集素 3 在妊娠期糖尿病孕婦中表達及與胰島素抵抗關系. 中國計劃生育學雜志, 2019, 27(1): 77-79, 83.
24. 鄭林, 李超, 齊衛紅, 等. 巨噬細胞移動抑制因子基因在胎盤組織中表達與妊娠期糖尿病的相關性. 中華醫學雜志, 2017, 97(43): 3388-3391.
25. 李華珍, 袁俏奇, 羅利, 等. 妊娠期糖尿病產婦胎盤與血清脂聯素水平的相關性. 中南醫學科學雜志, 2016, 44(3): 255-257.
26. 左嬋. 探討脂聯素在妊娠期糖尿病發病機制中的相關作用. 湛江: 廣東醫學院, 2012.
27. 李明. PI3K/AKT 信號通路與妊娠期糖尿病胰島素抵抗的關系. 天津: 天津醫科大學, 2010.
28. 曹聰明, 丁紅濤, 李妙榮. 妊娠期糖尿病患者胎盤組織中胎球蛋白 A 的表達及其與胰島素抵抗的關系. 中國醫師進修雜志, 2014, 37(27): 7-9.
29. 周玉彬, 李超, 喬炳龍, 等. 妊娠期糖尿病患者胎盤組織中雌激素與雌激素受體α水平變化及相關因素分析. 中華糖尿病雜志, 2017, 9(11): 688-692.
30. Shang M, Dong X, Hou L. Correlation of adipokines and markers of oxidative stress in women with gestational diabetes mellitus and their newborns. J Obstet Gynaecol Res, 2018, 44(4): 637-646.
31. Johns EC, Denison FC, Norman JE, et al. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends in Endocrinol Metab, 2018, 29(11): 743-754.
32. Koning SH, Hoogenberg K, Lutgers HL, et al. Gestational diabetes mellitus: current knowledge and unmet needs. J Diabetes, 2016, 8(6): 770-781.
33. Feng H, Su R, Song Y, et al. Positive correlation between enhanced expression of TLR4/MyD88/NF-κB with insulin resistance in placentae of gestational diabetes mellitus. PloS one, 2016, 11(6): e0157185.
34. Plows JF, Stanley JL, Baker PN, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci, 2018, 19(11): 3342.
35. Low Birth Weight and Nephron Number Working Group. The impact of kidney development on the life course: a consensus document for action. Nephron, 2017, 136(1): 3-49.
36. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest, 2005, 115(5): 1111-1119.
37. Liang ZX, Du MK, Fang Q, et al. Significance of RBP4 in patients with gestational diabetes mellitus: a case-control study of Han Chinese women. Gynecol Endocrinol, 2014, 30(2): 161-164.
38. 劉嗣超, 劉星. PAI-1、GLUT1 及 RBP4 在妊娠期糖尿病患者胎盤組織中的表達及臨床意義. 中國婦幼保健, 2019, 34(19): 4430-4433.
39. Pérez-Pérez A, Maymó J, Gambino Y, et al. Insulin enhances leptin expression in human trophoblastic cells. Biol Reprod, 2013, 89(1): 20.
40. Pérez-Pérez A, Guadix P, Maymó J, et al. Insulin and leptin signaling in placenta from gestational diabetic subjects. Horm Metab Res, 2016, 48(1): 62-69.
41. Hu S, Liu Q, Huang X, et al. Serum level and polymorphisms of retinol-binding protein-4 and risk for gestational diabetes mellitus: a meta-analysis. BMC Pregnancy Childbirth, 2016, 16: 52.
42. Sudharshana Murthy KA, Bhandiwada A, Chandan SL, et al. Evaluation of oxidative stress and proinflammatory cytokines in gestational diabetes mellitus and their correlation with pregnancy outcome. Indian J Endocrinol Metab, 2018, 22(1): 79-84.
43. Tabák AG, Carstensen M, Witte DR, et al. Adiponectin trajectories before type 2 diabetes diagnosis: WhitehallⅡstudy. Diabetes Care, 2012, 35(12): 2540-2547.
44. Siddiqui K, George TP, Nawaz SS, et al. Serum adipokines (adiponectin and resistin) correlation in developing gestational diabetes mellitus: pilot study. Gynecol Endocrinol, 2018, 34(6): 502-506.
45. Asemi Z, Jazayeri S, Najafi M, et al. Association between markers of systemic inflammation, oxidative stress, lipid profiles, and insulin resistance in pregnant women. ARYA Atheroscler, 2013, 9(3): 172-178.
46. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes, 2002, 51(7): 2207-2213.
47. Xu J, Zhao YH, Chen YP, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. Sci World J, 2014, 2014: 926932.
48. 趙莉莉, 楊筱青. 妊娠期糖尿病 TNF-α與 VCAM-1 的表達及相關性研究. 醫學研究雜志, 2019, 48(4): 78-82.
49. Khambule L, George JA. The role of inflammation in the development of GDM and the use of markers of inflammation in GDM screening. Adv Exp Med Biol, 2019, 1134: 217-242.
50. 楊娟, 佘美華. FoxO1 在 2 型糖尿病中的作用及其研究進展. 中南醫學科學雜志, 2017, 45(3): 307-311.
51. 侯少聰, 李平平. 半乳糖苷凝集素 Galectin3 直接誘發胰島素抵抗. 中國細胞生物學學報, 2017, 39(5): 537-541.
52. Hepp P, Unverdorben L, Hutter S, et al. Placental galectin-2 expression in gestational diabetes: a systematic, histological analysis. Int J Mol Sci, 2020, 21(7): 2404.
53. 馮慧, 馬京梅, 楊慧霞. 妊娠期糖尿病孕婦足月胎盤 Toll 樣受體 4 的表達分布. 中華圍產醫學雜志, 2016, 19(5): 350-354.
54. 王運林, 姚培偉, 張曉婷. 炎性因子 hs-CRP、MIF 和 RANTES 在不同糖代謝人群中的表達及其與胰島素抵抗的關系. 廣東醫學, 2015, 36(12): 1897-1899.
55. 李高振, 宋曉燕. 巨噬細胞移動抑制因子及腫瘤壞死因子-α在妊娠期糖尿病臨床診斷中的應用價值. 實用臨床醫藥雜志, 2017, 21(23): 86-87.
56. Shang M, Zhao J, Yang L, et al. Oxidative stress and antioxidant status in women with gestational diabetes mellitus diagnosed by IADPSG criteria. Diabetes Res Clin Pract, 2015, 109(2): 404-410.
57. 張亞楠, 陳保民, 高陽, 等. FoxO3a 轉錄因子與機體氧化應激損傷的研究進展. 醫學研究生學報, 2016, 29(3): 327-331.
58. 楊猛, 高天虹. 蛋白酪氨酸磷酸酶 1B (PTP1B) 抑制劑的研究進展. 河南化工, 2015, 32(1): 11-15.
59. Akbas H, Kahraman S, Sak S, et al. Minor variant of AHSG gene 767C> G polymorphism may decrease the risk of gestational diabetes mellitus. J Obstet Gynaecol, 2020, 40(3): 303-307.
60. 王雨艷, 黃達, 沈秀敏, 等. 雌激素受體和孕激素受體在妊娠期高血壓疾病胎盤組織中的表達. 解剖科學進展, 2015, 21(6): 621-623.
61. Barros RP, Morani A, Moriscot A, et al. Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4. Mol Cell Endocrinol, 2008, 295(1/2): 24-31.

Previous Article
The clinical and pathological characteristics of advanced colorectal adenomatous polyps
Next Article
Thoughts on the construction of internet hospitals from the perspective of PDCA

West China Medical Journal

The relationship between differential placental protein expressions and insulin resistance: a systematic review and meta-analysis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content